Sepha, the Belfast, Northern Ireland-based packaging machinery expert, has developed what it claims is the world’s first tool-less vision-based leak detection machine for blister-packs.
Adaptive clinical design can lead to significant time savings when implemented successfully, claims a new study by Cutting Edge Information, the North Carolina, US-based business consultancy firm.
Suven Life Sciences’ facility in Pashamylaram, India has been cleared for the production active pharmaceutical ingredients (APIs) and intermediates by the US FDA.
Regulatory demands for ‘in process’ performance data have changed the pharma sector’s approach to materials analysis and enhanced the quality of the drugs it produces according to Freeman Technology.
Pharmaceutical giant Pfizer has agreed to sell Capsugel, its drug delivery technology unit, to US investment group Kohlberg Kravis Roberts & Co (KKR) for $2.4bn (€1.7bn).
Double-digit growth in the Chinese pharmaceutical sector will increasingly make the nation a lucrative place for Western companies to do business, delegates heard at the InterPhex trade event in New York.
The pharmaceutical manufacturing sector in Puerto Rico will thrive because of and not in spite of changes to the country’s tax and incentive laws according to the Puerto Rico Industrial Development Company (PRIDCO).
Chiltern International, a global contract research organisation (CRO) has expanded its European operations with the opening of a new office in the Netherlands.
Michigan, US-based clinical research organisation (CRO), Imperial, has completed the acquisition of clinical trial specialists, D. Anderson & Company for an undisclosed fee.
ATMI LifeSciences has introduced a new method of integrity testing for its range of single-use bioprocess vessels that, it claims, will take QA in the biomanufacturing sector to a new level.
Comprehensive Clinical Development, a contract research organisation based in Florida, US, has finalised the acquisition of clinical trials specialist, Charles River Clinical Services.
A new, tougher approvals policy for pharmaceutical products in China will bring opportunities for Western contract companies able to help domestic firms meet the strict new rules, according to a seminar at InterPhex in New York.
Chinese (API) maker ScinoPharm said that it met its sales targets in 2010, despite rocketing raw materials prices, cutbacks in government healthcare spending in key markets and currency revaluation.
Planning the commercial production and delivery of effective cell therapies will be key if the sector is to achieve forecast growth of $6bn within nine years, according to a seminar at the InterPhex trade event in New York City.
Almac Diagnostics, a branch of UK-based contract research organisation (CRO), Almac, has opened a Clinical Laboratory Improvement Amendments (CLIA) registered lab at its headquarters in Craigavon, Northern Ireland.
PHT, a provider of electronic patient reported outcome (ePRO) services used in clinical trials, has launched a web browser-based ePRO system to collect patient data over the internet.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at PPD, Clinilabs, Clearstone and Clariant.
The US FDA set out its support for properly planned continuous manufacturing during a fascinating opening presentation at the first day of Interphex 2011 in New York, US yesterday.
The US Food and Drug Administration (FDA) has issued a new advisory designed to help drugmakers prevent the formation of glass fragments in vials following a spate of recent recalls.
West Pharmaceutical Services has moved to expanded its offering by partnering on the development of a new needle-free technology for drug reconstitution with hospital supply giant Carefusion.
Perceptive Informatics, an eClinical solutions provider, has announced the results of a survey to find out what the biopharma industry considers the most important eClinical attributes.
US contract manufacturing organisation (CMO) Catalent has reported that no employees were injured in the fire that occurred at its packaging facility in the UK last week.
Novartis has acquired a majority stake in vaccine maker Zhejiang Tianyuan Bio-Pharmaceutical, continuing its efforts to accelerate revenue growth in China.
Almac Pharma Services has expanded its cold storage capacity for biopharmaceuticals, continuing the contract manufacturing organisation’s (CMO) busy expansion programme.
Scientists from the University of Syracuse’s chemistry department have created a new drug delivery system which they claim will improve the efficacy of cancer-killing drugs.
Contract research organisation (CRO) Quintiles gained new ‘first-in-human’ (FIH) trial capacity yesterday with the opening of an ‘experimental medicine hub’ at Guy’s Hospital in London, UK.
The Southern Research Institute has partnered with the Biomedical Research Foundation of Northwest Louisiana (BRFNL) on non-invasive preclinical imaging.
US CRO Quintiles has postponed a financing plan it announced earlier this month, citing unfavourable global credit market conditions as the reason for the decision.
Gerresheimer has bought Brazilian pharmaceutical plastic packaging maker Vedat, citing rapid growth of the country’s drug market, particularly the generics segment, as the main driver for the acquisition.
Copley Scientific, the Nottingham, UK-based lab equipment manufacturer, has confirmed delivery of eight tablet dissolution testers to contract research organisation (CRO), Melbourn Scientific.